Comments
Commented by Fabian Lorenz on March 6th, 2025 | 08:10 CET
After thyssenkrupp, Ballard Power's share price is now exploding! Is First Phosphate next?
The Ballard Power share has made a strong comeback. On the back of a major order, it rose by 13%. Is there more to come? It seems that way for the First Phosphate share. The price decline of the past few weeks offers an attractive entry opportunity. The Canadians have reported on the current development of their phosphate activities. High revenues are expected from the investments, and the impact of US tariffs should be manageable. In any case, management is buying the stock. Investors have been snapping up thyssenkrupp shares in a big way this year. The price has doubled in a few weeks. Will it continue?
Read
Commented by Armin Schulz on March 6th, 2025 | 07:10 CET
dynaCERT – In the fast lane with hydrogen technology and CO2 certificates
The world is at a critical crossroads in terms of decarbonization. Developed countries are increasingly relying on regulatory levers to force change. For example, from 2025, EU fleet operators will have to drastically reduce their CO₂ emissions per km, while in the US, stricter limits for heavy-duty commercial vehicles will apply from 2027. However, the road to compliance is rocky: half of European companies are not yet aware of the new reporting requirements, and over 20% of fleets lack emissions data altogether. As a result, the market for climate technology is booming. But what solutions can bridge the gap between regulatory pressure and operational implementation? The focus is on companies that build bridges between ambitious goals and practical applicability. In this context, it is worth taking a look at players like dynaCERT, whose technology comes into play precisely where politics, climate science, and operational reality collide.
Read
Commented by André Will-Laudien on March 6th, 2025 | 07:00 CET
NETRAMARK HOLDINGS – Medical Revolution: How AI is Shortening Drug Approval by Years!
Artificial Intelligence – now it is really taking off in the medical field! Among many other applications, big data and artificial intelligence (AI) applications are revolutionizing the optimization of clinical phases in drug approval by accelerating processes, reducing costs, and significantly increasing the success rate. AI can analyze large amounts of data from electronic health records, genomic data, and patient registries to identify suitable clinical trial participants more quickly and accurately. This significantly reduces recruitment time and improves accuracy. Machine learning can be used to analyze previous study results to develop more efficient study designs. Based on real-time data, adaptive study protocols enable dynamic adjustment of experimental conditions. The Canadian technology company NetraMark Holdings Inc. (WKN: A3D5X9 | ISIN: CA64119M1059 | Ticker symbol: AIAI) develops solutions for the pharmaceutical industry to utilize Generative Artificial Intelligence (Gen AI).
Read
Commented by Stefan Feulner on March 5th, 2025 | 08:00 CET
C3.ai, Credissential, Strategy – Strong momentum
Donald Trump has many plans and visions associated with his slogan "Make America Great Again". One of these is that the "capital for artificial intelligence and cryptocurrencies" should be located in the United States. With the Stargate Project, which has a volume of over USD 500 billion, a program for investing in AI has been approved. Over the weekend, the Republican followed up by introducing a strategic cryptocurrency reserve, which caused the introduced currency pairs to take off.
Read
Commented by Fabian Lorenz on March 5th, 2025 | 07:30 CET
Hensoldt and Power Metallic Mines unstoppable! Buy AIXTRON stock after the price crash?
The success story is set to continue under a new name: Power Nickel has changed its name to Power Metallic Mines. In order to push ahead with the world-class multi-metal project at full speed, fresh capital has been raised. With new strong drilling results in the pipeline, the stock can now take off again. The price drop due to the capital increase represents an exciting entry opportunity. Investors certainly believe in higher prices. Hensoldt is currently skyrocketing. While the stock is being included in a new stock market index, analysts are running after the price and proclaiming a "new era". Will the momentum continue? At AIXTRON, analyst opinions are divided after the price crash. Is the stock a buy now? Management believes so.
Read
Commented by Armin Schulz on March 4th, 2025 | 07:10 CET
Deutsche Telekom, MiMedia, Xiaomi – On the trail of powerful growth drivers
Today, we are looking at three companies that have recently caused a stir. All of them are active in promising fields of technology, rely on intelligent expansion, and deliver impressive growth figures. Whether through smart product innovations, collaborations with industry giants, or global market strategies – they are united by the pursuit of efficiency and sustainable success. In this context, the Mobile World Congress 2025 in Barcelona is making headlines this month. New network standards, AI-supported services, and global partnerships illustrate the surge in innovation from which these three companies are also benefiting.
Read
Commented by Armin Schulz on March 4th, 2025 | 07:00 CET
BYD, Nova Pacific Metals, Nordex – From raw materials to electric vehicles or wind turbines: The strategies behind the boom
In a world caught between climate targets and geopolitical tensions, three companies in seemingly different industries are driving the green transformation with disruptive technology and strategic foresight. In recent months, the EU has announced two infrastructure packages worth billions for renewable energies and critical raw materials. Whether e-mobility, mineral raw materials or wind power – they all share one goal: to redefine their sectors. However, the starting point is always the raw materials needed for the electrification of the world.
Read
Commented by Armin Schulz on March 3rd, 2025 | 07:40 CET
Novo Nordisk, NetraMark Holdings, BioNTech – How three pioneers are paving the way for tomorrow's medicine
On January 6, 2025, the FDA announced new guidelines for AI-powered clinical trials to accelerate the approval of life-saving therapies. This has put a spotlight on companies that combine technology and biotechnology. They are addressing pressing challenges: chronic widespread diseases, complex cancer progression, and inefficient drug development. With artificial intelligence, mRNA platforms, and strategic alliances, they are revolutionizing not only therapies but also the way pharmaceutical companies research and scale up. However, the road is rocky – regulatory hurdles, supply bottlenecks, and the race for the next blockbuster shape their stories. Who are the players disrupting billion-dollar markets with innovative approaches?
Read
Commented by André Will-Laudien on March 3rd, 2025 | 07:35 CET
Biotech: Takeover candidates for 2025! Things are heating up at Evotec, BioNxt, Bayer, and Formycon!
The DAX 40 index is hitting new highs, following a gigantic wave of buying from the US. The rally is already well advanced, but due to ongoing geopolitical upheavals, high-tech and defense stocks are still performing well. In recent weeks, the positive trends have also spread to the biotech sector again. Stocks such as BioNxt have already gained over 150% in the last six months. What is driving this? Formycon has seen a severe price drop, while Bayer and Evotec are slowly getting back on track. Are we going to see takeovers now? What are the triggers for dynamic investors?
Read
Commented by Stefan Feulner on March 3rd, 2025 | 07:20 CET
Bloom Energy, Benton Resources, Alibaba – Exceptional performance
The scandal in the Oval Office between Ukrainian President Zelenskyy and US President Trump was a defining topic in recent days. The outcome remains uncertain from both a political and economic perspective. Will the missed peace talks now lead to a further downward spiral, or will negotiations be resumed, which could lead to an early end to the terrible war in Ukraine and a rally in the markets? Unaffected by global politics, several companies demonstrated strong momentum and could continue their upward trajectory.
Read